Monkeypox variant cause a surge in cases, WHO issues the highest-level global alert. Which stocks may benefit form this

The recent surge in monkeypox cases, driven by a more transmissible variant and heightened concern, has prompted the World Health Organization (WHO) to issue the highest-level global alert. This situation is likely to create opportunities for companies in the vaccine, antiviral drug, and protective equipment industries. Below are the stocks that may benefit from this situation: 1. **Vaccine Producers** - Aadi Bioscience (AADI) - Achieve Life (ACHV) - Adaptimmune (ADAP) - ADC Therapeutics (ADCT) - ADMA Biologics (ADMA) - Acasti Pharma (ACST) - Adial (ADIL) - Abbvie (ABBV) - Aurora Cannabis (ACB) - Adicet Bio (ACET) |code|stock code|stock name|last-price|last-change|GICS Industry|market_code| |---|---|---|---|---|---|---| |AADI|AADI.O|Aadi Bioscience|1.39|-0.714285714285715|Pharmaceuticals|186| |ACHV|ACHV.O|Achieve Life|4.38|0.5740528128587707|Pharmaceuticals|186| |ADAP|ADAP.O|Adaptimmune|1.04|-0.9523809523809532|Pharmaceuticals|185| |ADCT|ADCT.N|ADC Therapeutics|2.85|0.35211267605634616|Pharmaceuticals|169| |ADMA|ADMA.O|ADMA Biologics|17.57|1.7371163867979196|Pharmaceuticals|186| |ACST|ACST.O|Acasti Pharma|2.42|1.2552301255230043|Pharmaceuticals|186| |ADIL|ADIL.O|Adial|0.9651|-1.0153846153846176|Pharmaceuticals|186| |ABBV|ABBV.N|Abbvie|193.0|0.9255869894891023|Pharmaceuticals|169| |ACB|ACB.O|Aurora Cannabis|6.87|2.6905829596412514|Pharmaceuticals|186| |ACET|ACET.O|Adicet Bio|1.37|5.3846153846153895|Pharmaceuticals|185| 2. **Antiviral Drug Makers** - The companies listed above may also benefit from the increased demand for antiviral drugs, as they often produce both vaccines and treatments. 3. **Protective Equipment Manufacturers** - Adagio Medical (ADGM) - Abbott Laboratories (ABT) - Aethlon Medical (AEMD) - Allurion (ALUR) - Alcon (ALC) - Align Technology (ALGN) - Autonomix Medical (AMIX) - American Shared (AMS) - Accuray (ARAY) - Artivion (AORT) |code|stock code|stock name|last-price|last-change|GICS Industry|market_code| |---|---|---|---|---|---|---| |ADGM|ADGM.O|Adagio Medical|5.12|-12.627986348122871|Health Care Equipment & Supplies|186| |ABT|ABT.N|Abbott Laboratories|109.89|1.5243902439024444|Health Care Equipment & Supplies|169| |AEMD|AEMD.O|Aethlon Medical|0.3849|15.933734939759036|Health Care Equipment & Supplies|186| |ALUR|ALUR.N|Allurion|0.6938|-10.822622107969158|Health Care Equipment & Supplies|169| |ALC|ALC.N|Alcon|93.61|0.699225473321865|Health Care Equipment & Supplies|169| |ALGN|ALGN.O|Align Technology|220.03|0.0909793931674424|Health Care Equipment & Supplies|185| |AMIX|AMIX.O|Autonomix Medical|0.609|-5.140186915887855|Health Care Equipment & Supplies|186| |AMS|AMS.A|American Shared|3.11|2.268990463663267|Health Care Equipment & Supplies|170| |ARAY|ARAY.O|Accuray|1.43|-1.3793103448275874|Health Care Equipment & Supplies|185| |AORT|AORT.N|Artivion|24.51|-2.27272727272726|Health Care Equipment & Supplies|169| These companies are poised to benefit from the increased demand for their products and services as the global community responds to the monkeypox outbreak. The urgency of the situation, coupled with the potential for further spread, is likely to drive increased investment in preventive measures and treatments.